Home > Journals > Minerva Oftalmologica > Past Issues > Minerva Oftalmologica 2017 June;59(2) > Minerva Oftalmologica 2017 June;59(2):38-41

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   Freefree

Minerva Oftalmologica 2017 June;59(2):38-41

DOI: 10.23736/S0026-4903.17.01775-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The effect of oral supplementation with standardized bilberry extract (Mirtoselect®) on retino-cortical bioelectrical activity in severe diabetic retinopathy

Fabio MAZZOLANI 1, Stefano TOGNI 2, Federico FRANCESCHI 2, Roberto EGGENHOFFNER 3, Luca GIACOMELLI 3

1 Private Practitioner, Milan, Italy; 2 Indena SpA, Milan, Italy; 3 Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy


PDF


BACKGROUND: Diabetic retinopathy is a common complication of diabetes mellitus (DM) that affects the microcirculation of the eye. DM patients with or without signs of retinopathy showed a significant reduction in amplitude and latency of their retino-cortical bioelectrical activity assessed by the Visual Evoked Potential (VEP) Test. Here, we aim at investigating the effects of an oral supplementation of standardized bilberry extract (Mirtoselect®) on VEP parameters of DM patients.
METHODS: Nine patients affected by type 2, non-insulin DM associated with severe preproliferative retinopathy were enrolled in this preliminary, supplement study. A pattern-reversal VEP analysis was performed at baseline and after 1-month oral supplementation with 320 mg/day of bilberry extract standardized to 36% anthocyanins (Mirtoselect®).
RESULTS: P100 amplitude and waveform in 4 patients (44.4% of all patients) improved following 1-month oral supplementation. In these subgroup of patients we observed an overall normalization of the VEP response to visual stimuli.
CONCLUSIONS: Dietary supplementation with standardized bilberry extract (Mirtoselect®) represents an alternative strategy to support eye health and control or prevent the worsening of retinopathy symptoms in DM patients.


KEY WORDS: Diabetic retinopathy - Vaccinium myrtillus - Evoked potentials, visual - Electrophysiology - Dietary supplements

top of page